Report: AstraZeneca, Pfizer, Novartis home in on Onyx bids

Tracy Staton

, and are still in the hunt for Pharmaceuticals, Bloomberg's sources say. And Amgen, which triggered the whole bidding process with an unsolicited offer last month, hasn't given up either.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS